The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
me change notification emails
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
Funding Opportunity Number:
Feb 12, 2009
Feb 12, 2009
Original Closing Date for Applications:
Jan 07, 2012
Current Closing Date for Applications:
Jan 07, 2012
Feb 07, 2012
Funding Instrument Type:
Category of Funding Activity:
Food and Nutrition
Expected Number of Awards:
Estimated Total Program Funding:
Alcohol Research Programs
Drug Abuse and Addiction Research Programs
Discovery and Applied Research for Technological Innovations to Improve Human Health
Cancer Cause and Prevention Research
Cancer Detection and Diagnosis Research
Cancer Treatment Research
Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement:
Additional Information on Eligibility:
National Institutes of Health
Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to solicit Small Business Innovation Research (STTR) grant applications from small business concerns (SBCs) that propose to develop resources, research tools, instrumentations, biomarkers, devices, drugs or new and innovative approaches to diagnosis, monitoring, management, treatment and prevention of liver diseases. Areas of interest include development of reliable and practical means of diagnosis of liver diseases; biomarkers for disease activity and stage; noninvasive tests for inflammation, fibrosis and fat in the liver; and drugs, complementary and alternative modalities, biologics or molecular reagents for the therapy or prevention of liver diseases. The goal of this announcement is to enlist members of the small business research community in advancing means of diagnosis, treatment and prevention of liver disease and facilitate the goals outlined in the trans-NIH Action Plan for Liver Disease Research.
Mechanism of Support. This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-095, that encourages applications under the Small Business Innovation Research (SBIR) (R43/R44) grant mechanisms.
Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received.